![Giovanni de Castro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Giovanni de Castro
Directeur Technique/Scientifique/R&D chez Melt Pharmaceuticals, Inc.
Postes actifs de Giovanni de Castro
Sociétés | Poste | Début | Fin |
---|---|---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Directeur Technique/Scientifique/R&D | 01/11/2021 | - |
Historique de carrière de Giovanni de Castro
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Health Technology |
- Bourse
- Insiders
- Giovanni de Castro
- Expérience